Blood tests could replace risky biopsies for transplant patients
NCT ID NCT04855422
Summary
This study is testing two new blood tests to see if they can safely and accurately detect organ rejection in people who have received a combined kidney and pancreas transplant. The goal is to find better ways to spot rejection early without needing invasive biopsies. Researchers will monitor 42 transplant recipients to see how well these tests work compared to current methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSPLANT; COMPLICATION, REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
Conditions
Explore the condition pages connected to this study.